Read More

Vision Marine Technologies Inc. Announces $3M Private Placement Of Convertible Preferred Shares and Warrants; Will Not Complete Public Offering, Withdraws Effectiveness Of Previously Filed Registration Statement

Will not complete public offering, withdraws effectiveness of previously filed registration statementMONTREAL, QC / ACCESSWIRE / December 14, 2023 / Vision Marine Technologies Inc. (NASDAQ:VMAR) ("Vision Marine" or the

VMAR

Read More

Prelude Therapeutics Entered Into A Securities Purchase Agreement With Institutional Investors, To Which The Company Agreed To Issue And Sell Pre-Funded Warrants To Purchase Up To 7,936,759 Shares Of Voting Common Stock At A Price Of $3.1499 Per Warran…

On December 11, 2023, Prelude Therapeutics Incorporated, a Delaware corporation (the "Company"), entered into a securities purchase agreement (the "Securities Purchase Agreement") with certain institutional accredited

PRLD